A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation

Dipenkumar Modi; Zaid Al-Kadhimi; Wei Chen; Hyejeong Jang; Abhinav Deol; Lois Ayash; Divaya Bhutani; Asif Alavi; Voravit Ratanatharathorn; Joseph P. Uberti

doi:10.1002/ajh.25035

A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation

Dipenkumar Modi, Zaid Al-Kadhimi, Wei Chen, Hyejeong Jang, Abhinav Deol, Lois Ayash, Divaya Bhutani, Asif Alavi, Voravit Ratanatharathorn, Joseph P. Uberti

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	E96-E98
Journal	American Journal of Hematology
Volume	93
Issue number	4
DOIs	https://doi.org/10.1002/ajh.25035
State	Published - Apr 2018
Externally published	Yes

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.25035

Cite this

Modi, D., Al-Kadhimi, Z., Chen, W., Jang, H., Deol, A., Ayash, L., Bhutani, D., Alavi, A., Ratanatharathorn, V., & Uberti, J. P. (2018). A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation. American Journal of Hematology, 93(4), E96-E98. https://doi.org/10.1002/ajh.25035

Modi, D, Al-Kadhimi, Z, Chen, W, Jang, H, Deol, A, Ayash, L, Bhutani, D, Alavi, A, Ratanatharathorn, V & Uberti, JP 2018, 'A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation', American Journal of Hematology, vol. 93, no. 4, pp. E96-E98. https://doi.org/10.1002/ajh.25035

@article{68ae533dadcb43b6aa4b6fa0b779f1bd,

title = "A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation",

author = "Dipenkumar Modi and Zaid Al-Kadhimi and Wei Chen and Hyejeong Jang and Abhinav Deol and Lois Ayash and Divaya Bhutani and Asif Alavi and Voravit Ratanatharathorn and Uberti, {Joseph P.}",

year = "2018",

month = apr,

doi = "10.1002/ajh.25035",

language = "English (US)",

volume = "93",

pages = "E96--E98",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "4",

}

TY - JOUR

T1 - A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation

AU - Modi, Dipenkumar

AU - Al-Kadhimi, Zaid

AU - Chen, Wei

AU - Jang, Hyejeong

AU - Deol, Abhinav

AU - Ayash, Lois

AU - Bhutani, Divaya

AU - Alavi, Asif

AU - Ratanatharathorn, Voravit

AU - Uberti, Joseph P.

PY - 2018/4

Y1 - 2018/4

UR - http://www.scopus.com/inward/record.url?scp=85041578777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041578777&partnerID=8YFLogxK

U2 - 10.1002/ajh.25035

DO - 10.1002/ajh.25035

M3 - Letter

C2 - 29318650

AN - SCOPUS:85041578777

SN - 0361-8609

VL - 93

SP - E96-E98

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 4

ER -

A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this